News

Takeda Pharmaceutical Reports 15% Decline in First-Quarter Net Profit

1 Mins read

Takeda Pharmaceutical, the Japanese drugmaker, announced a 15% decrease in its first-quarter net profit compared to the previous year, despite experiencing revenue growth in various key business areas. The net profit for the quarter ended June 30 amounted to ¥89.395 billion ($637.4 million). It is important to note that the year-earlier period had seen a rise in the company’s bottom line due to financial gains associated with acquisitions.

The reported profit fell below the estimate of ¥113.53 billion as predicted by a poll of analysts conducted by S&P Global Market Intelligence.

On a positive note, Takeda’s first-quarter revenue saw a year-on-year increase of 8.9%, reaching ¥1.059 trillion. This growth can be attributed to a weaker yen and expansion in key business sectors, except for oncology. Notably, sales of the ulcerative colitis drug Entyvio surged by 14% from the previous year, amounting to ¥192.0 billion.

Moreover, Takeda’s operating profit margin demonstrated improvement, rising to 15.9% compared to 15.5% in the same period last year.

Despite these financial results, Takeda Pharmaceutical has decided to maintain its revenue and net-profit projections for the fiscal year ending in March 2024. The company expects a 4.7% decline in revenue, totaling ¥3.840 trillion, and anticipates a 55% decrease in net profit, amounting to ¥142.00 billion.

Related posts
News

Funeral home owner accused of stashing decaying bodies expected to plead guilty in federal court

1 Mins read
DENVER – A funeral home owner in Colorado accused of storing nearly 190 decomposing bodies in a room-temperature building and defrauding the…
News

Has the Airbnb bubble burst?

2 Mins read
Only 4% of Americans are considering Airbnb for their next vacation according to a survey from forex giant Travelex. As part of…
News

Tinubu has changed narrative of NDDC, says Ogbuku, MD

21 Mins read
Managing director of the Niger Delta Development Commission (NDDC), Dr. Samuel Ogbuku, in this interview, spoke on the leadership reforms in the…

Leave a Reply

Your email address will not be published. Required fields are marked *